A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
I7O-MC-JOBA - ClinicalTrials.gov - NCT02529553
The main purpose of this study is to evaluate the safety of the study drug known as LY3076226 in participants with advanced or metastatic cancer.
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Advanced CancerWhat the trial is testing?
LY3076226Could I receive a Placebo?
NoEnrollment Goal
25Trial Dates
Sep 1, 2015 - Mar 28, 2018How long will I be in the trial?
Your participation may continue for as long as you and your study doctor feel that you are benefiting from the study treatment.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo